Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Drugs--cost”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1979

[Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].

In addition to a clinical study which investigated the bio-availability of three oral iron preparations S, L and X by using postabsorption serum iron concentration curves, the same drugs were compared in order to study their antianaemic efficacy, tolerance and drug costs arising during and iron therapy. Moreover, these iron drugs were related to other current clinical reports. Within all three iron preparations a very good correlation was found between bio-availability and haematopoietic efficacy: The very good absorbability of the bivalent quick release stick capsule preparation S (= 100%) corresponded with a very good capacity of haemoglobin regeneration (2,6 +/- 0,4 g Hb/1/day) whereas due to a very low absorbability (10% to 16%) the antianaemic efficacy of both iron(III) preparations L and X had to be rated as moderate to predominantly poor. In normal therapeutic dosis all three iron preparations showed no differences in tolerance. The ratio of side effects was similar to that after ingestion of placebo. In comparing the drug costs during a therapy leading to a real absorption of 1 g of iron the most effective iron(II)sulfate preparation S is 3.6 to 12.6 times cheaper than the compared trivalent preparations L and X. Therefore, there is no justification for the further production or introduction on the market of trivalent iron preparations.

Absorption↗
PubMed1977

[The structure of drug costs. A criticism of monocausal explanation (author's transl)].

Proceeding from the arguments of a recent publication, an attempt is made to establish whether a monocausal assessment is fruitful in the explanation of the development of drug costs in the statutory health insurance. The question is raised whether the price increase for drugs is in fact the decisive variable determining the costs. This is denied on the grounds of a differential analysis of the causative variables involved and it is shown what role, besides price and quantity components, the innovation or structure effect plays in the development of drug costs.

Age Factors↗
PubMed1979

Maximum allowable cost: can the government control drug costs?

In 1973 the federal government moved to limit drug reimbursement to providers in federally sponsored or supported programs, to the lowest cost at which the drug is generally and consistently available unless a difference in therapeutic effect can be demonstrated between the brand name and generic drug. This paper examines the political evolution and rationale for this program and explores the issues surrounding the ongoing controversy regarding publicly financed programs offering drug benefits. The authors speculate that the government's first attempt to control prices of pharmaceuticals, prior to enactment of some form of national health insurance, if successful, will call forth pharmaceutical industry strategies which could negate program benefits.

Cost Control↗
PubMed1977

Drug costs.

Explore the source record for details and available documents.

Advertising↗
PubMed1977

Drug costs.

Explore the source record for details and available documents.

Communication↗
PubMed1976

Drug costs.

Explore the source record for details and available documents.

Cost-Benefit Analysis↗
PubMed1978

Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program.

Costs and use of antimicrobial agents in 1976 at 19 hospitals were surveyed by review of pharmacy records. Total costs of antimicrobial drugs at individual hospitals ranged from $0.65 to $1.75 per patient day and accounted for 16% to 41% of total pharmacy drug costs. There was marked variation among hospitals in use of specific antimicrobial agents, especially cephalosporins and clindamycin. The cephalosporin and aminoglycoside antibiotics accounted for 66% of the total cost of antimicrobial agents. An 18-month antimicrobial drug control program at one hospital decreased antimicrobial drug costs by 31%. The major effect was in reducing cephalosporin use. The results of the control program document that a significant portion of hospital antimicrobial use is inappropriate and can be eliminated without apparent detriment to patient care.

Anti-Bacterial Agents↗
PubMed1978

Brief versus standard hospitalization: the differential costs.

The authors compared the use of inpatient and day care services, number of readmissions, use of special services, use of drugs, costs to family and community, and differential dollar costs of three treatment approaches--brief hospitalization followed by day care, brief hospitalization followed by outpatient care, and standard hospitalization. They found that, among patients who had families willing to care for them, brief hospitalization followed by either day or outpatient care was less expensive in terms of hospital costs and costs to the family than standard hospitalization.

Aftercare↗
PubMed1979

The relationship between female criminality and drug use.

A 2-year study of four groups of women (N = 268)--addicts, prostitute-addicts, prostitutes, and female offenders--reveals that the link between female criminal activity and female drug involvement is significant. All four groups report "drug costs" as a major percentage of their monthly expenses. Prostitutes and female offenders report purchasing drugs mainly for resale. Female offenders report most of their income as coming from drugs sales, shoplifting, and larceny. For all of the women addicted to heroin, reselling drugs and prostitution were the usual means of support. There is insufficient evidence at this point in the research to link the use of a specific category of drugs to specific types of offenses. The main determinants in choice of crime for these subjects were skill and opportunity.

Adolescent↗
PubMed1979

Surveillance of antibiotics use in a community hospital.

An ongoing system of antibiotic surveillance was initiated in a community hospital. The system was based on the guideline audits of antimicrobial use published by the Veterans Administration Ad Hoc Interdisciplinary Advisory Committee on Antimicrobial Drug Usage. The surveillance is accepted well by the medical staff. It has proved to be cost-effective and educational. A changing pattern of antimicrobial drug use has been recognized that has resulted in decreased antimicrobial drug costs.

Anti-Bacterial Agents↗
PubMedDate not supplied

Some aspects of tuberculoid leprosy and chemotherapeutic trials.

The author describes the progress made in our knowledge of tuberculoid leprosy since the original case of Jadassohn in 1898. The numerical importance of T patients in different parts of the world is reviewed and their role in the transmission of the disease discussed. An analysis is made of the subgroups into which T leprosy is divided according to the clinical symptoms, bacteriology, histopathology and immunology in the Madrid classification as well as in the Souza-Lima-Souza Campos and Ridley-Jopling studies. The author concludes that a majority of T patients are immunologically stable and belong to two well defined groups, the first called T annular in the Souza-Lima-Souza Campos study and TT in the Ridley-Jopling classification and the second called T reactional by S.L.-S.C. and BT by R.J. Taking into account the high proportion of T cases in most epidemiological situations, their generally accepted good prognosis under treatment and the present availability of several drugs of proved efficacy, the author suggests to carry out in T leprosy under controlled conditions a trial of a number of therapeutic regimens of not more than 12 months duration. Follow-up periods will make possible medium and long-term evaluation of results after 3 and 5 years respectively of the initiation of the chemotherapeutic regimens. The practical implications of effective and well tolerated short-term therapy in T leprosy is stressed. Its widespread use in field programmes will represent among other advantages a considerable economy in personnel and drugs costs. The use of a single protocol is recommended. The one worked out by THELEP for therapeutic trials in lepromatous leprosy could be adopted with a few changes made necessary because of the morphological and bacteriological differences between L and T leprosy. It is suggested that, if the results of the trial are successful, similar regimens could be tried in indeterminate leprosy.

Clinical Trials as Topic↗
PubMed1979

The office emergency cart.

Two mobile emergency resuscitative carts have been described. One, in use in a major dental school in the United States, has been estimated to cost $8,000 to $10,000. The second, with essentially the same equipment and drugs, costs about $2,800 and is feasible for an office situation. It helps to solve two problems. First, it provides a ready, compact, and organized method for the storage and maintenance of emergency resuscitative drugs and equipment. Second, it provides a vehicle by which the medical emergency resuscitative expertise of the oral and maxillofacial surgeon may be extended and utilized.

Dental Care↗
PubMed1979

Developing drug-use profiles from drug-charge records.

The potential for developing a drug-use profile from drug-charge records was studied at an 830-bed community hospital. Patient drug charges were reviewed retrospectively for one year (1975) to identify: (1) which key drugs accounted for a high percentage of cost and usage; (2) where key drugs were used within the hospital; (3) how they were used; and (4) who were the chief prescribers. Of the drugs used, 8% accounted for 80% of total drug product costs. Seven drug groups (10% of the total drug groups) appeared in the top 10 of both drug cost and quantity categories. Six individual drugs also appeared in the top 10 of both categories. According to cost, cephalosporin antibiotics were ranked first among drug groups but were sixth according to quantity. Analgesics-antipyretics were ranked first among drug groups by quantity and second by cost. Cephalothin was ranked first among individual drugs by cost and was not in the top 10 in quantity. Diazepam was ranked first among individual drugs by quantity and third by cost. Patients' drug-charge records can be used effectively to generate drug-use profiles for ongoing drug use review, quality assurance and cost containment programs.

California↗
PubMed1978

[Drug prescription and distribution on the wards. Evaluation of questionnaires (author's transl)].

Weaknesses in the practice of drug prescription and distribution on the wards are presented as the result of this survey. Suggestions for improvement are made which seem suitable for increasing drug safety and reducing drug costs. It should be possible to implement the suggested improvements without much expense. Probably, these improvements would hardly involve any additional time expenditure, since complete documentation, as suggested inter alia, might eliminate time-consuming queries and searching.

Berlin↗